Luteolin upregulates phase 2 detoxifying enzymes (HO-1 and NQO-1) in male Sprague-Dawley rats with intracerebral hemorrhage-induced secondary brain damage (intraperitoneal administration) and male ICR mice (oral administration) [51,131]. This evidence concerns the gene HMOX1 and intracerebral hemorrhage.